Concomitant functional gastrointestinal symptoms influence psychological status in Korean migraine patients

Gut and Liver

Volumn 7, Issue 6, 2013, Pages 668-674

  Park, Jeong Wook ^a   Cho, Young Seok ^a   Lee, Soo Yeon ^a   Kim, Eun Sun ^a   Cho, Hyunjung ^b   Shin, Hae Eun ^a   Suh, Gyoung Im ^a   Choi, Myung Gyu ^c  

^a Uijeongbu St Mary's Hospital   (South Korea)

^b Korea University of Technology and Education   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Gastrointestinal diseases; Headache related disability; Migraine disorders; Prevalence; Psychological comorbidity

Indexed keywords

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; BLOATING; COMORBIDITY; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEARTBURN; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA AND VOMITING; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT;

GASTROINTESTINAL DISEASES; HEADACHE-RELATED DISABILITY; MIGRAINE DISORDERS; PREVALENCE; PSYCHOLOGICAL COMORBIDITY;

ADOLESCENT; ADULT; AGED; ANXIETY; COMORBIDITY; DEPRESSION; DISABILITY EVALUATION; DYSPEPSIA; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NAUSEA; PREVALENCE; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; VOMITING; YOUNG ADULT;

EID: 84888591640     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2013.7.6.668     Document Type: Article

References (37)

1. Roh JK, Kim JS, Ahn YO. Epidemiologic and clinical characteristics of migraine and tension-type headache in Korea. Headache 1998;38:356-365.
2. Centonze V, Polito BM, Cassiano MA, et al. The dyspeptic syndrome in migraine: morphofunctional evaluation on 53 patients. Headache 1996;36:442-445.
3. Meucci G, Radaelli F, Prada A, et al. Increased prevalence of migraine in patients with uninvestigated dyspepsia referred for open-access upper gastrointestinal endoscopy. Endoscopy 2005;37:622-625.
4. Kurth T, Holtmann G, Neufang-Hüber J, Gerken G, Diener HC. Prevalence of unexplained upper abdominal symptoms in patients with migraine. Cephalalgia 2006;26:506-510.
5. Aamodt AH, Stovner LJ, Hagen K, Zwart JA. Comorbidity of headache and gastrointestinal complaints. The Head-HUNT Study. Cephalalgia 2008;28:144-151.
6. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol 2006;6:26.
7. Ferrari A, Leone S, Vergoni AV, et al. Similarities and differences between chronic migraine and episodic migraine. Headache 2007;47:65-72.
8. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140-1156.
9. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 Suppl 1:9-160.
10. Shin HE, Park JW, Kim YI, Lee KS. Headache Impact Test-6 (HIT-6) scores for migraine patients: their relation to disability as measured from a headache diary. J Clin Neurol 2008;4:158-163.
11. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.
12. Park JM, Choi MG, Cho YK, et al. Functional gastrointestinal disorders diagnosed by Rome III questionnaire in Korea. J Neurogastroenterol Motil 2011;17:279-286.
13. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 2001;56(6 Suppl 1):S20-S28.
14. Bayliss MS, Dewey JE, Dunlap I, et al. A study of the feasibility of Internet administration of a computerized health survey: the headache impact test (HIT). Qual Life Res 2003;12:953-961.
15. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893-897.
16. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
17. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992;304:87-90.
18. Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther 2004;20:1195-1203.
19. Azpiroz F, Dapoigny M, Pace F, et al. Nongastrointestinal disorders in the irritable bowel syndrome. Digestion 2000;62:66-72.
20. Mulak A, Paradowski L. Migraine and irritable bowel syndrome. Neurol Neurochir Pol 2005;39(4 Suppl 1):S55-S60.
21. Riedl A, Schmidtmann M, Stengel A, et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 2008;64:573-582.
22. Faure C, Patey N, Gauthier C, Brooks EM, Mawe GM. Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients. Gastroenterology 2010;139:249-258.
23. Ferrari MD, Odink J, Tapparelli C, Van Kempen GM, Pennings EJ, Bruyn GW. Serotonin metabolism in migraine. Neurology 1989;39:1239-1242.
24. Hudson JI, Mangweth B, Pope HG Jr, et al. Family study of affective spectrum disorder. Arch Gen Psychiatry 2003;60:170-177.
25. Park JM, Choi MG, Park JA, et al. Serotonin transporter gene polymorphism and irritable bowel syndrome. Neurogastroenterol Motil 2006;18:995-1000.
26. Park JW, Han SR, Yang DW, Kim YI, Lee KS. Serotonin transporter protein polymorphism and harm avoidance personality in migraine without aura. Headache 2006;46:991-996.
27. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999;45 Suppl 2:II37-II42.
28. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479.
29. Hejazi RA, McCallum RW. Review article: cyclic vomiting syndrome in adults: rediscovering and redefining an old entity. Aliment Pharmacol Ther 2011;34:263-273.
30. Stickler GB. Relationship between cyclic vomiting syndrome and migraine. Clin Pediatr (Phila) 2005;44:505-508.
31. Wang Q, Ito M, Adams K, et al. Mitochondrial DNA control region sequence variation in migraine headache and cyclic vomiting syndrome. Am J Med Genet A 2004;131:50-58.
32. Hejazi RA, Reddymasu SC, Namin F, Lavenbarg T, Foran P, McCallum RW. Efficacy of tricyclic antidepressant therapy in adults with cyclic vomiting syndrome: a two-year follow-up study. J Clin Gastroenterol 2010;44:18-21.
33. Jeong JJ, Choi MG, Cho YS, et al. Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol 2008;14:6388-6394.
34. Oedegaard KJ, Neckelmann D, Mykletun A, et al. Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The HUNT Study. Cephalalgia 2006;26:1-6.
35. Guidetti V, Galli F, Fabrizi P, et al. Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 1998;18:455-462.
36. Haug TT, Mykletun A, Dahl AA. Are anxiety and depression related to gastrointestinal symptoms in the general population? Scand J Gastroenterol 2002;37:294-298.
37. Seng EK, Holroyd KA. Psychiatric comorbidity and response to preventative therapy in the treatment of severe migraine trial. Cephalalgia 2012;32:390-400.